March, 2020 Congress will be working on the Fiscal Year 2021 budget for weeks to come, so you can still make your voice heard for lupus research. If you haven’t already, please go online TODAY and use the automated tools of our Legislative Action Center to tell legislators what lupus research means to their constituents […] READ MORE
March 9, 2020 A newly published study showed that antimalarial medications, a common form of treatment for lupus, may help prevent type 2 diabetes mellitus (T2DM), which can be a complication of the disease and a side effect of medications like glucocorticosteroids. Researchers reviewed health databases in British Columbia Canada to study the incidence of […] READ MORE
March 4, 2020 A new study showed that living in a disadvantaged neighborhood predicts poor retention (follow-up) care for people with lupus. Retention was defined specifically has having two out-patient doctor visits or lab tests such as measuring complement levels. Researchers looked at the records of 397 patients with lupus in terms of age, sex, […] READ MORE
Updated March 11, 2020 On behalf of our lupus community, the Lupus Research Alliance is following closely reports from the U.S. Centers for Disease Control and Prevention (CDC), the country’s health protection agency, about the Coronavirus Disease 2019 called COVID-19. People with lupus are predisposed (at greater risk) to infections because of both their disease […] READ MORE
Poner al día 11 Marzo de 2020 En nombre de nuestra comunidad de lupus, la Alianza para la investigación de Lupus (Lupus Research Alliance) está siguiendo de cerca los informes de los Centros para el Control y la Prevención de Enfermedades de los Estados Unidos (CDC), la agencia de protección de la salud del país, […] READ MORE
February 27, 2020 A new study supported by the Lupus Research Alliance discovered that molecules called type II interferons can trigger the immune system to over-produce the B cells that cause lupus inflammation. Type I interferons have already been shown to be very important in lupus which has led to exciting new drugs like anifrolumab […] READ MORE
February 27, 2020 A study led by Lupus Research Alliance grantee Dr. J. Michelle Kahlenberg of the University of Michigan has revealed one reason why people with lupus tend to get rashes. Dr. Kahlenberg and her team found that certain immune system molecules produced by people with lupus help bacteria gain a foothold on the […] READ MORE
February 20, 2020 The Lupus Research Alliance (LRA) works hard, often in concert with organizations like the National Minority Quality Forum to alleviate disparities in healthcare among groups at particular risk for lupus, including African-Americans as the group hardest hit by the disease. Several programs educate healthcare providers, patients and the public to better recognize […] READ MORE
February 20, 2020 Black History Month is particularly important to the Lupus Research Alliance because this group is hardest hit by lupus. There’s no better time than the month aimed at celebrating this group to look forward and take action on their own behalf. African Americans are three times more likely to have the disease, […] READ MORE
NEW YORK, NY. Feb. 14. In recognition of National Organ Donor Day, the Lupus Research Alliance (LRA) is launching a new campaign to encourage people with lupus to think with their hearts to help scientists solve how and why lupus can impact the brain. To address brain-related issues, the LRA has partnered with the Harvard […] READ MORE
The 2020 Wichita Walk with Us to Cure Lupus presented by GSK is the Lupus Research Alliance’s national fundraising program. The Lupus Research Alliance is the largest private sector organization dedicated to advancing lupus research. Walk distance is approximately 5k (3.1 miles) Contact Joanna Zelkowska at lupuswalkwichita@lupusresearch.org or at 646-884-6014. Register Now ► READ MORE
February 6, 2020 The complexity of lupus has been a challenge for decades, but advances in human immunology, technology, and computation offer a new and unique opportunity to speed up major advances. The time is right to bring personalized medicine to lupus treatment. And going into 2020, the Lupus Research Alliance (LRA) is seizing that […] READ MORE
